Technical Analysis for BCDA - Biocardia Inc.

Grade Last Price % Change Price Change
grade A 14.0 -17.65% -3.0000
BCDA closed down 17.65 percent on Thursday, August 1, 2019, on 1.19 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical BCDA trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -17.65%
Pocket Pivot Bullish Swing Setup -17.65%
Wide Range Bar Range Expansion -17.65%
New 52 Week High Strength -17.65%
Upper Bollinger Band Walk Strength -17.65%

Older signals for BCDA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
BioCardia, Inc., formerly Tiger X Medical, Inc., is a clinical-stage regenerative medicine company. The Company is engaged in developing therapeutics for cardiovascular diseases. The Company's lead therapeutic candidate is the CardiAMP Cell Therapy System (CardiAMP). It focuses on the Phase III trial for CardiAMP in ischemic systolic heart failure. The Company also offers CardiALLO Cell Therapy System (CardiALLO), an allogeneic off the shelf mesenchymal stem cell product candidate from other donors. It focuses on the Phase II trial for CardiALLO for the treatment of ischemic systolic heart failure. The Company focuses on various fields of autologous and allogeneic cell-based therapies to manage the lives of patients with cardiovascular conditions. CardiAMP is a therapeutic treatment that includes a companion diagnostic. It consists of a cell potency screening test, a point of care cell processing platform and a biotherapeutic delivery system.
Biotechnology Branches Of Biology Life Sciences Biology Stem Cells Regenerative Medicine Cell Biology Cell Therapy Therapy Cardiovascular Diseases Regenerative Biomedicine Heart Failure Stem Cell Therapy Mesoblast
Is BCDA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 17.5
52 Week Low 0.9
Average Volume 5,450
200-Day Moving Average 2.1052
50-Day Moving Average 3.1376
20-Day Moving Average 6.0558
10-Day Moving Average 10.329
Average True Range 1.6096
ADX 51.82
+DI 56.3992
-DI 5.1038
Chandelier Exit (Long, 3 ATRs ) 12.6712
Chandelier Exit (Short, 3 ATRs ) 5.7788
Upper Bollinger Band 16.0314
Lower Bollinger Band -3.9198
Percent B (%b) 0.9
BandWidth 329.456059
MACD Line 3.1698
MACD Signal Line 2.1596
MACD Histogram 1.0102
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.3750
Resistance 3 (R3) 17.7500 17.0000 16.8125
Resistance 2 (R2) 17.0000 16.1405 16.8125 16.6249
Resistance 1 (R1) 15.5000 15.6095 15.1250 15.1250 16.4374
Pivot Point 14.7500 14.7500 14.5625 14.5625 14.7500
Support 1 (S1) 13.2500 13.8905 12.8750 12.8750 11.5626
Support 2 (S2) 12.5000 13.3595 12.3125 11.3752
Support 3 (S3) 11.0000 12.5000 11.1875
Support 4 (S4) 10.6250